-
1
-
-
34548682706
-
-
Conférence de consensus de l'ANAES. Traitement de l'hépatite C. Février 2002.
-
Conférence de consensus de l'ANAES. Traitement de l'hépatite C. Février 2002.
-
-
-
-
2
-
-
0034324083
-
Pegylated interferon alfa-2b: Pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data
-
Glue P, Fang JW, Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, et al. Pegylated interferon alfa-2b: pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data. Clin Pharmacol Ther, 2000;68:556-67.
-
(2000)
Clin Pharmacol Ther
, vol.68
, pp. 556-567
-
-
Glue, P.1
Fang, J.W.2
Rouzier-Panis, R.3
Raffanel, C.4
Sabo, R.5
Gupta, S.K.6
-
3
-
-
0036830454
-
Side effects of therapy of hepatitis C and their management
-
Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology, 2002;36:237-4.
-
(2002)
Hepatology
, vol.36
, pp. 237-234
-
-
Fried, M.W.1
-
4
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
Manns MP, Mc Hutchinson JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet, 2001;358:958-65.
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
Mc Hutchinson, J.G.2
Gordon, S.C.3
Rustgi, V.K.4
Shiffman, M.5
Reindollar, R.6
-
5
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med, 2002;347:975-82.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
Smith, C.4
Marinos, G.5
Goncales Jr, F.L.6
-
6
-
-
0642314315
-
Management of newly diagnosed hepatitis C virus infection
-
Russo MW, Zacks SL, Fried MW. Management of newly diagnosed hepatitis C virus infection. Cleve Clin J Med, 2003;70(Suppl 4):14-20.
-
(2003)
Cleve Clin J Med
, vol.70
, Issue.SUPPL. 4
, pp. 14-20
-
-
Russo, M.W.1
Zacks, S.L.2
Fried, M.W.3
-
7
-
-
23444460553
-
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin
-
Ferenci P, Fried MW, Shiffman ML, Smith CI, Marinos G, Goncales FL Jr, et al. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin. J Hepatol, 2005;43:425-33.
-
(2005)
J Hepatol
, vol.43
, pp. 425-433
-
-
Ferenci, P.1
Fried, M.W.2
Shiffman, M.L.3
Smith, C.I.4
Marinos, G.5
Goncales Jr, F.L.6
-
8
-
-
1442282967
-
Guidelines for stopping therapy in chronic hepatitis C
-
Russo MW, Fried MW. Guidelines for stopping therapy in chronic hepatitis C. Curr Gastroenterol Rep, 2004;6:17-21.
-
(2004)
Curr Gastroenterol Rep
, vol.6
, pp. 17-21
-
-
Russo, M.W.1
Fried, M.W.2
-
9
-
-
0028323634
-
Acute onset of ocular complications with interferon
-
Yamada H, Mizobuchi K, Isogai Y. Acute onset of ocular complications with interferon. Lancet, 1994;343:914.
-
(1994)
Lancet
, vol.343
, pp. 914
-
-
Yamada, H.1
Mizobuchi, K.2
Isogai, Y.3
-
10
-
-
4143101297
-
Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection
-
Willson RA. Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection. J Clin Gastroenterol, 2004;38:717-22.
-
(2004)
J Clin Gastroenterol
, vol.38
, pp. 717-722
-
-
Willson, R.A.1
-
11
-
-
0038282524
-
Interferon-associated retinopathy
-
Savant V, Gillow T. Interferon-associated retinopathy. Eye, 2003;17:534-6.
-
(2003)
Eye
, vol.17
, pp. 534-536
-
-
Savant, V.1
Gillow, T.2
-
12
-
-
33745447903
-
Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C
-
Okuse C, Yotsuyanagi H, Nagase Y, Kobayashi Y, Yasuda K, Koike K, et al. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol, 2006;12:3756-9.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 3756-3759
-
-
Okuse, C.1
Yotsuyanagi, H.2
Nagase, Y.3
Kobayashi, Y.4
Yasuda, K.5
Koike, K.6
-
13
-
-
9644258505
-
Is screening for interferon retinopathy in hepatitis C justified?
-
Cuthbertson FM, Davies M, McKibbin M. Is screening for interferon retinopathy in hepatitis C justified? Br J Ophthalmol, 2004;88:1518-20.
-
(2004)
Br J Ophthalmol
, vol.88
, pp. 1518-1520
-
-
Cuthbertson, F.M.1
Davies, M.2
McKibbin, M.3
-
14
-
-
4444248245
-
Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin
-
Farel C, Suzman DL, McLaughlin M, Campbell C, Koratich C, Masur H et al. Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin. AIDS, 2004;18:1805-9.
-
(2004)
AIDS
, vol.18
, pp. 1805-1809
-
-
Farel, C.1
Suzman, D.L.2
McLaughlin, M.3
Campbell, C.4
Koratich, C.5
Masur, H.6
-
15
-
-
0000310101
-
Prospective study of the incidence of interferon-induced retinopathy in patients with chronic hepatitis
-
Nao-i N, Matuura Y, Sawada A. Prospective study of the incidence of interferon-induced retinopathy in patients with chronic hepatitis. Ophtalmology, 1994;101(Suppl):119.
-
(1994)
Ophtalmology
, vol.101
, Issue.SUPPL.
, pp. 119
-
-
Nao-i, N.1
Matuura, Y.2
Sawada, A.3
-
16
-
-
20444501429
-
Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C
-
Yaghi C, Baz P, Koussa S, Daniel F, Haddad F, Sayegh R. Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C. Gastroenterol Clin Biol, 2005;29:616-7.
-
(2005)
Gastroenterol Clin Biol
, vol.29
, pp. 616-617
-
-
Yaghi, C.1
Baz, P.2
Koussa, S.3
Daniel, F.4
Haddad, F.5
Sayegh, R.6
-
17
-
-
6344282654
-
Bilateral AION after the combined therapy of hepatitis C with PEG-interferon alpha2B and ribavirin
-
Kirchhoff A, Kirchhoff U, Lafrenz M, Guthoff R. Bilateral AION after the combined therapy of hepatitis C with PEG-interferon alpha2B and ribavirin. Klin Monatsbl Augenheilkd, 2004;221:791-3.
-
(2004)
Klin Monatsbl Augenheilkd
, vol.221
, pp. 791-793
-
-
Kirchhoff, A.1
Kirchhoff, U.2
Lafrenz, M.3
Guthoff, R.4
-
18
-
-
0346753461
-
Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy
-
Vardizer Y, Linhart Y, Loewenstein A, Garzozi H, Mazawi N, Kesler A. Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy. J Neuroophthalmol, 2003;23:256-9.
-
(2003)
J Neuroophthalmol
, vol.23
, pp. 256-259
-
-
Vardizer, Y.1
Linhart, Y.2
Loewenstein, A.3
Garzozi, H.4
Mazawi, N.5
Kesler, A.6
-
19
-
-
16344382588
-
Retinal toxicity during pegylated alpha-interferon therapy for chronic hepatitis C: A multifocal electroretinogram investigation
-
Chisholm JA, Williams G, Spence E, Sparks S, Keating D, Gavin M et al. Retinal toxicity during pegylated alpha-interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation. Aliment Pharmacol Ther, 2005;21:723-32.
-
(2005)
Aliment Pharmacol Ther
, vol.21
, pp. 723-732
-
-
Chisholm, J.A.1
Williams, G.2
Spence, E.3
Sparks, S.4
Keating, D.5
Gavin, M.6
-
20
-
-
1842459212
-
Retinopathy caused by interferon alpha associated with ribavirin therapy and the importance of the electro-oculogram: A case report
-
Crochet M, Ingster-Moati I, Even G, Dupuy P. Retinopathy caused by interferon alpha associated with ribavirin therapy and the importance of the electro-oculogram: a case report. J Fr Ophtalmol, 2004;27:257-62.
-
(2004)
J Fr Ophtalmol
, vol.27
, pp. 257-262
-
-
Crochet, M.1
Ingster-Moati, I.2
Even, G.3
Dupuy, P.4
|